FDA APPROVES VALTREX

Article

The FDA has approved a supplemental new drug application for Valtrex (valacyclovir HCI) manufactured by GlaxoSmithKline.

Related Videos
Related Content

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Eczema Resources for Your Patients: Week 1

October 2nd 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Eczema Resources for Your Patients: Week 1

October 2nd 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Eczema Resources for Your Patients: Week 1

October 2nd 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023
© 2023 MJH Life Sciences

All rights reserved.